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Abstract 
Cytofectins are positively charged lipophilic molecules that readily form complexes with DNA and other anionic polynucleotides. 
Normally, cytofectins are combined with an activity-augmenting phospholipid such as dioleoylphosphatidylethanolamine (DOPE), and a 
film of dried, mixed lipid is prepared and hydrated to form cationic liposomes. The liposome solution is then mixed with a plasmid DNA 
solution to afford cytofectin-DNA complexes which, when presented to living cells, are internalized and the transgene is expressed. One 
of the most potent cytofectins, dimyristoyl Rosenthal inhibitor ether (DMRIE), is presently being used to deliver transcriptionally active 
DNA into human tumor tissues. Here we report the remarkable consequences of replacing the alcohol moiety of DMRIE with a primary 
amine. The resulting cytofectin, called P-aminoethyl-DMRIE ( PAE-DMRIE), promoted high level transfection over a broad range of 
DNA and cationic lipid concentrations. A comparison of in vitro transfection activity between DMRIE and /3AE-DMRIE in 10 cell types 
revealed that PAE-DMRIE was more active than DMRIE, and that PAE-DMRIE, unlike DMRIE, was maximally effective in the 
absence of colipid. The consequences of the alcohol-to-amine conversion on the structure of the cytofectin/DNA complex was also 
examined by Atomic Force Microscopy. Strikingly dissimilar images were found for plasmid DNA alone and for the plasmid complexes 
of /?AE-DMRIE and DMRIE/DOPE. 
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1. Introduction 
Cytofectins are used increasingly to deliver functionally 
active polynucleotides into cells. Several cytofectins are 
available commercially for the transfection of cultured 
cells (e.g., Lipofectin@, LipofectACE” , LipofectAMINE’, 
Transfeactam@, and DOTAP”). Two cytofectins, DMRIE 
(dimyristoyl Rosenthal inhibitor ether) and DC-cholesterol 
(dimethylaminoetbylcarbamoyl cholesterol) are currently 
being used in human clinical gene therapy trials to deliver 
DNA into cells [l-9]. It is presently unclear which chemi- 
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cal and physical properties of cytofectins are responsible 
for their ability to deliver polynucleotides into cells [lo]. 
Most cytofectins reported to date possess long chain hy- 
drocarbon groups attached to a polar head group. The more 
active cytofectins possess a net positive charge, and associ- 
ate into layered structures containing multiple positive 
charges on the surface. The cytofectins described to date 
require mixing with ‘neutral’, zwitterionic lipids such as 
DOPE (dioleoylphoshatidylethanolamine) in order to elicit 
optimal polynucleotide delivery activity [ 1 l- 141. By com- 
bining cytofectins with neutral lipids, a liposome is formed 
that possesses properties of both amphipathic substituents. 
Such composite liposomes are usually much more effec- 
tive at transfection than either substituent alone. The net 
polycationic surface of cationic liposomes is likely to 
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interact strongly with the polyanionic phosphate backbone 
of polynucleotides. If cationic charges are present on the 
surface of the polynucleotide/cytofectin/neutral lipid 
complex, then the complex should interact strongly with 
the predominantly negative charge of the cell surface. 
DMRIE, one of the most active cytofectins described to 
date, has a quaternary nitrogen adjacent to a primary 
alcohol, thus imparting a pH independent positive charge. 
It was predicted that substituting a primary amine group 
for the alcohol of DMRIE would: (1) maintain and perhaps 
enhance the cytofectin’s ability to hydrogen bond with 
DNA, a property which has been shown to be important 
[lO,l 11; (2) increase the cytofectin’s net positive charge; 
(3) allow bidentate interactions between the quatemary 
nitrogen/primary amine and polyanionic structures. This 
amino compound, termed PAE-DMRIE ( P-aminoethyl- 
DMRIE), was synthesized and compared with DMRIE. 
PAE-DMRIE was found to form structurally distinct com- 
plexes with DNA compared to DMRIE, and /?AE-DMRIE, 
unlike DMRIE, was generally able to transfect cells effec- 
tively in the absence of helper co-lipids. 
2. Materials and methods 
2.1. DNA preparation and quality control 
The two plasmid DNAs used in these studies, pVCL- 
1005 (495 1 bps) and pRSV-LacZ (53 19 bps), code for, 
respectively, human HLA-B7 + fi 2 microglobulin proteins 
[ 1,2] and bacterial P-galactosidase [6]. Eucaryotic expres- 
sion of both plasmids is regulated by the RSV promoter. 
Bulk amounts of plasmid were prepared as described 
[l&16]. Briefly, the plasmid DNAs were transformed into 
Escherichia coli DHSa competent cells and grown in 
Terrific Broth supplemented with 100 pg/ml ampicillin in 
a 5L Fermenter (Applikon). Temperature was controlled at 
30°C + 0.5”C, pH was controlled at 7.0 + 0.5, stirring at 
600 rpm f 50 ‘pm, and air flow was set at 5 l/l/min. 
Cells were harvested by centrifugation at the end of expo- 
nential growth phase. Covalently closed circular plasmid 
DNA was isolated by a modified lysis procedure (no use 
of enzymes, but the use of salt precipitation to reduce 
RNA contamination) followed by standard double CsCl- 
ethidium bromide gradient ultracentrifugation. Endotoxin 
was determined by the Limulus Amebocyte Lysate (Asso- 
ciates of Cape Cod) assay and protein was determined by 
the Bicinchoninic acid (BCA; Pierce) All plasmid prepara- 
tions were free of detectable chromosomal DNA and RNA 
and from protein impurities based on gel analysis and 
BCA assay, respectively. Endotoxin levels were less than 
60 EU/pg of plasmid DNA. The A&A,,, ratios were 
between 1.75 and 2.00. Plasmids were ethanol precipitated 
and the DNA was resuspended in USP saline at 4°C until 
dissolved. Aliquots of DNA were stored at -76°C until 
use. 
2.2. Cytofectin componenB 
2.2.1. (k )-N-(2-HydroxyethylJ-N,N-dimethyl-2,3- 
bis(tetradecyloxy)-I-propanaminium bromide (DMRIE) 
The intermediate from which the cationic lipids were 
made, (k j-N, N-dimethyl-(2,3-bis(tetradecyloxy))pro- 
pylamine, or (DMP-DMA), was prepared as follows. 
Racemic I-dimethylamino-2,3-propanediol(l.96 g; Janssen 
Chimica) was converted to the disodium salt in situ by 
treatment with sodium hydride (60% in oil, 1.65 g) in 
tetrahydrofuran (110 ml>. Condensation with tetradecyl 
methane sulfonate (10.1 g; NuChekPrep) afforded crude 
DMP-DMA. This material was purified to homogeneity by 
extraction and then silica gel chromatography employing a 
step gradient of ether in hexane. The structure and purity 
were confirmed by ‘H-NMR and IR. I H-NMR (CDCl,, 
TMS): 6 3.6-3.4 (overlapping m, 7H), 2.38 (m, 2H), 2.26 
6, 6H), 1.54 (m, 4H), 1.25 (s, 44H), 0.88 (t, J = 6.7 Hz, 
6H). IR (film): cm-’ 2900, 1450, 1110, 725. 
For DMRIE preparation, DMP-DMA (5.12 g) was 
treated with bromoethanol (2.19 g) in dimethylformamide 
(15 ml) at elevated temperature (1 lO”C, overnight) to 
effect quatemization of the amine. Evaporative removal of 
the dimethylformamide followed by silica gel chromatog- 
raphy employing chloroform/methanol/aqueous ammonia 
as eluant afforded homogenous material. The expected 
structure and purity were confirmed by ‘H-NMR, IR, and 
elemental analysis. ’ H-NMR (CDCI,, TMS): 6 5.01 (t, 
J= 5.8 Hz, lH), 4.16 (br. s, 2H), 4.08 (m, lH), 3.95-3.60 
(overlapping m, 4 H), 3.55 (d, J = 4.1 Hz, 2H), 3.5 l-3.3 
(overlapping m  and s, 9 H), 1.55 (m, 4H), 1.26 (s, 44H), 
0.88 (t, J = 6.7 Hz, 6H). IR (KBr): cm-’ 3300 (br), 1460, 
1060, 955, 725. Elemental analysis [C,SH,,O,NBr]: talc. 
C: 66.00, H: 11.71, N: 2.20, Br: 12.55; found C: 66.13, H: 
11.58, N: 2.10, Br: 12.75. 
2.2.2. (k )-N-(2-Aminoethyl)-N,N-dimethyl-2,3-bisctetrade- 
cyloaykI -propanaminium bromide (p AE-DMRIE) 
DMP-DMA (4 g) was treated with 2- 
bromoethylphthalimide (4 g; Aldrich) in dimethylform- 
amide (15 ml) at elevated temperature (1 lO”C, overnight) 
to effect quatemization of the amine. Evaporative removal 
of the dimethylformamide followed by silica gel chro- 
matography employing chloroform/methanol/aqueous 
ammonia as eluant afforded TLC homogenous material. 
The structure of the /3-phthalimido intermediate was con- 
firmed by ’ H-NMR and IR. ‘H-NMR (CDCl,, TMS): 13 
7.86 (m, 2H), 7.76 (m, 2H), 4.3-4.0 (overlapping m, 6H), 
3.7-3.6 (overlapping m  and s, 11 H), 3.35 (t, J = 6.7 Hz, 
2H), 1.54 (m, 2H), 1.47 (m, 2H), 1.25 (s, 44H), 0.88 (t, 
J = 6.7 Hz, 6H). IR (KBr): cm-’ 2800,2730, 1760, 1700, 
1010, 725. Deprotection of the primary amine was accom- 
plished by treatment of the phthalimide (1.8 g) with anhy- 
drous hydrazine (2.7 g) in anhydrous ethanol (40 ml). 
Filtration, evaporative removal of ethanol and extraction 
afforded the crude product which was purified to homo- 
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3. Results 
The molecular structures of the lipid reagents used in 
this study are shown in Fig. 1. In /?AE-DMRIE, a primary 
amino group replaces the primary alcohol in DMRIE. This 
substitution should confer a positive charge of roughly 1.5 
on PAE-DMRIE at physiological pH (7.4) based on the 
pK, values reported for ethylenediamine [20]. Thus, on 
average, PAE-DMRIE has a greater net positive charge 
than DMRIE (about + 1.5 vs. + 1.0). The primary amine 
moiety may possibly possess an enhanced hydrogen bond- 
ing capability compared to DMRIE as a consequence of its 
various protonation states. 
We compared the structure of plasmid DNA/PAE- 
DMRIE, DNA/DMRIE and DNA/DMRIE-DOPE cyto- 
fectin complexes by Atomic Force Microscopy. The results 
are shown in Fig. 2. Fig. 2A and B shows the appearance 
of naked, uncomplexed plasmid DNA. All of the naked 
plasmid DNA images that attached to the mica were 
observed to be uniformly sized, overlapping loop images 
that are characteristic of a highly purified preparation of 
intact covalently closed circular plasmid DNA. Regions of 
the images that show increased height (whitish areas) are 
apparently areas of plasmid crossover and/or supercoiling 
[ 17,181. Condensation of plasmid DNA with PAE-DMRIE 
or DMRIE gave rise to distinct structural changes in the 
apparent plasmid backbone. All of the attached 
DMRIE Br 
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HO’-.‘-N 
-5 
Br- 
I ow 
PAE DMRIE 
I+O 
H2N-N 
4 
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O- 0 
Fig. 1, Cytofectin structural components. The chemical structures of the 
reagents used in this paper are shown. PAE-DMRIE and DMRIE were 
synthesized from a common intermediate. The /?AE-DMRIE contains a 
primary amine group while DMRIE contains a primary alcohol group. 
The neutral co-lipid used in this work was DOPE. 
DNA/PAE-DMRIE images appeared as compacted, irreg- 
ularly shaped branches and loops (Fig. 2C). All of the 
images observed when DNA/DMRIE complexes were 
examined with AFM appeared similar to images of plas- 
mid alone (not shown). By contrast, all of the attached 
DNA/DMRIE-DOPE images appeared as irregularly 
shaped globules (Fig. 2E). Under higher magnification, 
both DNA/PAE-DMRIE and DNA/DMRIE-DOPE com- 
plexes appeared to contain closely juxtaposed plasmid 
strands (Fig. 2D,F), although the interstrand juxtapositions 
appeared more frequent in DNA/DMRIE-DOPE prepara- 
tion. 
Virtually all cationic lipids used to deliver DNA into 
cells to date have required some proportion of a neutral 
lipid to be present in order to achieve optimal transfection 
activity [ 1 1 - 14,211. Rather than assume a uniform co-lipid 
requirement, the transfection activity of @AE-DMRIE and 
DMRIE was compared with 0, 25, 50, or 75 mol% of the 
neutral lipid, DOPE. These four formulations for each of 
the two cationic lipids (i.e., PAE-DMRIE and DMRIE 
alone and in combination with DOPE) were mixed with 
plasmid DNA in a 96 well plate before being presented in 
100 ~1 of serum-free culture medium to cells cultured in 
microwells arranged in an 8 X 8 matrix. Fig. 3 presents the 
format for transfection used in all the experiments reported 
in this study. Shown are cationic lipid and DNA amounts 
per well in pg units (Fig. 3, numbers in italics) and PM 
units (Fig. 3, italicized numbers in parenthesis) as well as 
the resulting well-by-well DNA/cationic lipid mass ratios 
(Fig. 3, bold numbers) and molar ratios (Fig. 3, bold 
numbers in parentheses). Thus, replicate cell cultures re- 
ceived DNA and cationic lipid amounts ranging from 
2.000 to 0.016 pg and 10.7 to 0.08 pg, respectively. The 
resulting DNA/cationic lipid mass ratios covered a 
12 OOO-fold range from 0.002 (well Hl) to 23.82 (well 
A8). Past experience with other cytofectins has shown that 
optimal DNA/cationic lipid ratios for cells generally falls 
within this range. 
The malignant mouse melanoma cell line, B 16F10, was 
transfected with 64 different nCMVintlacZ plasmid 
DNA/cationic lipid mixtures according the scheme out- 
lined above and the procedures stated in Section 2. The 
resulting typical well-by-well expression levels of p- 
galactosidase in pg per well are shown in Fig. 4. For 
presentation purposes. values in each well were catego- 
rized into three transfection groups, high, medium and low. 
For example, using DNA mixtures containing 100% 
PAE-DMRIE, well Al shown in Fig. 4A had a maximum 
transfection value of 11410 pg P-galactosidase. Values 
highlighted in black are those pg values that are from 
666100% of this maximum plate value (i.e., range 7606- 
1 1410 pg). Those values highlighted as grey wells fall 
between 33-66% of maximum (range 3802-7605 pg> and 
the unhighlighted values represent the bottom 33% (range 
O-3801 pg). Fig. 4A-D and F-I shows individual pg 
values per well. Fig. 4E and J shows the pg sums con- 
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geneity by recrystallization from hexane. The structure and 
purity were confirmed by ‘H-NMR, IR, high resolution 
mass spectroscopy, and elemental analysis. ’ H-NMR 
(CDCl,, TMS): S 4.1 (m, lH), 4.0-3.8 (overlapping 
multiplets, 3H), 3.7 (m, lH), 3.6-4.0 (overlapping m and 
s, 12 H), 3.29 (t, J = 6.1 Hz)2H), 1.55 (m, 4H), 1.26 (s, 
44H), 0.88 (t, J = 6.7 Hz, 6H). IR (KBr): cm-’ 3400 (b), 
2900, 2840, 1460, 1370, 1120, 725. High Resolution mass 
spectrum M’ [M - Br]: talc. 555.5828; found 555.5807. 
Elemental analysis [C,,H,,O,N,Br]: talc. C: 66.11, H: 
11.89, N: 4.41, Br: 12.57; found C: 66.61, H: 12.38, N: 
4.42, Br: 12.33. 
2.2.3. 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) 
Material of > 99% purity was purchased from Avanti 
Polar Lipids as a chloroform solution and used without 
further purification. 
2.3. Cytofectin formulation 
Solutions of DMRIE and PAE-DMRIE in chloroform 
were prepared on a weight to volume basis. Aliquots of 
cationic lipid and DOPE (when required) were transferred 
aseptically to sterile vials in amounts calculated to provide 
the relative and absolute lipid concentrations desired upon 
reconstitution with 1 ml of aqueous vehicle. Bulk chloro- 
form was removed with a stream of dry nitrogen, and the 
vials were treated with high vacuum overnight to remove 
any residual solvent. 
2.4. DNA-lipid complexes 
The dried, formulated cytofectin-neutral lipid mixture 
was suspended by vortexing in OPTIMEM (Gibco BRL). 
The Plasmid DNA was also diluted in OPTIMEM. The 
cytofectin-neutral lipid and DNA were diluted in OPTI- 
MEM to make a 2 X solution and 50 ~1 of each were 
mixed together with a multichannel pipette in 96 well 
plates at the desired mass/molar ratios. No precipitation 
occurred at the dilute solutions used as monitored by light 
microscopy. The DNA-lipid complexes were added to the 
cells within 2 h after mixing. 
2.5. Atomic force microscopy 
A 1 .O mg PAE-DMRIE/ml, 1 .O mg DMRIE or 1 .O mg 
DMRIE + 1.0 mg DOPE/ml were reconstituted into lipo- 
somes by vortexing the appropriate amount of thin dried 
lipid films in distilled water. An aliquot of either cationic 
liposome preparation was diluted to 0.1 mg cationic 
lipid/ml and 75 ~1 of it was mixed with 50 ~1 0.2 mg 
pVCL-1005 DNA/ml in water. This 125 ~1 solution 
contained 10 pg DNA and 7.5 pg cationic lipid, represent- 
ing a DNA/cationic lipid mass ratio of l/0.75. A 2 ~1 
aliquot of DNA or DNA/cytofectin complex was diluted 
with 200 ~1 of adhesion buffer (20 mM Tris-HCl, pH 7.5, 
5 mM MgC12, 0.1 mM EDTA, 1 mM dithiothreitol) and 
20 ~1 was deposited onto freshly cleaved mica, allowed to 
remain in place for 90 set, and the unadsorbed material 
was washed off with 6 drops of distilled water. The mica 
surface was then dried with a stream of nitrogen. The 
samples were imaged in air using a NanoScope II atomic 
force microscope Digital Instruments Inc., Santa Barbara, 
CA) [ 17,181. Commercially available silicon nitride cante- 
livers, 100 pm in length with a spring constant of 0.38 
N/m (Digital Instruments) with electron-beam deposited 
micro tips were used [ 191. At least 10 separate fields were 
examined for each sample and representative images are 
presented in Section 3. 
2.6. Cell lines 
All but three of the cell lines used in this study were 
obtained from the American Type Tissue Culture Collec- 
tion (ATCC) as follows: BHK-21 (Syrian hamster kidney, 
#CCL lo>, COS7 (African Green monkey SV40 trans- 
formed kidney, #CRL 165 11, C2C 12 (mouse muscle my- 
oblast, #CRL 17721, CV-1 (African Green monkey kid- 
ney, #CCL 701, B16-FO (mouse melanoma, #CRL 6322), 
HeLa (human epitheliod cervical carcinoma, #CCL 2) and 
3T3 (mouse fibroblast, #CRL 1658). The Renca mouse 
adenocarcinoma cells were a kind gift from Dr. Drew 
Pardoll at the Johns Hopkins University. The UM-449 
human melanoma and CT26 murine colon adenocarcinoma 
cells were kindly provided by Mark Cameron and Dr. Gary 
Nabel, respectively, at the University of Michigan. All 
cells were passaged 1:5 to 1: 10 in 10% fetal bovine serum 
(FBS) and Dulbecco’s modified Eagle’s medium (DMEM). 
All cells were expanded through 10 doubling passages 
upon receipt and aliquots were stored frozen. Upon re-ex- 
pansion, all cells were used for transfection studies before 
another 10 passages. 
2.7. Transfection assays 
On day 0, 20000 cells in 100 ~1 lO%FBS/90%DMEM 
were seeded into each well of 96-well culture plates 
(Nunc) and cultured overnight in a 5% CO, incubator at 
37°C. On day 1, the medium was aspirated carefully 
without dislodging cells, and 100 ~1 of the DNA-cationic 
lipid formulation in serum-free OPTIMEM (Gibco BRL) 
was added. After 4 h of culture, 50 ~1 30% FBS/70% 
OPTIMEM was added to each well. On day 2, each well 
received 100 ~1 10% FBS/90% OPTIMEM. On day 3 the 
medium was removed and 50 ~1 lysis buffer (0.1% Triton 
X-100 in 250 mM Tris, pH 8.0) was added and the plates 
were stored at - 70°C for least 2 h. After thawing, the well 
media were assayed for their content of P-galactosidase 
enzyme activity [ 111. 
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Fig. 2. Atomic force microscopy of plasmid DNA-cationic lipid complexes. Plasmid DNA alone (A,Bl and plasmid DNA complexed to either 
PAE-DMRIE (CD) or DMRIE-DOPE (E,F). Higher magnifications are shown in B,D, and F. Scales at the bottom of individual images denote dimension 
in the mica plane and vertical (color) scale is representative of relative heights. Image width to height ratios do not represent actual proportions due to 
differential resolution in the planar versus vertical dimensions (see Refs. [ 17.18,23] for a more detailed explanation). 
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tributed from the corresponding solid, shaded and open 
values for each plate. Both the pattern of expression 
(reflected as solid or shaded wells) and the,, total transfec- 
tion levels (Fig. 4E,J) varied less than 20% in replicate 
experiments (data not shown). 
In the absence of DOPE as co-lipid, PAE-DMRIE 
transfected B 16F10 cells over a much broader range of 
DNA/cytofectin ratios than did DMRIE (compare the 
number of solid or shaded values in Fig. 4A with those in 
F). The total levels of transfection achieved with 100% 
PAE-DMRIE was about 6-fold higher than that of 100% 
DMRIE (compare the 0% DOPE values in Fig. 4E and J). 
Even when formulated with DOPE, the PAE-DMRIE 
mediated high to medium level transfections of B 16FlO 
cells over a wider range of DNA/cationic lipid ratios than 
did the corresponding DMRIE-DOPE mediated transfec- 
tions (compare the number and position of the solid and 
shaded wells in Fig. 4B with G, C with H, and D with I). 
As was true when comparing with cationic lipids without 
DOPE, total transfection levels using j?AE-DMRIE with 
DOPE were consistently higher than those using DMRIE 
with DOPE (compare the 75%, 50% and 25% values in 
Fig. 4E and J). And finally, the transfection levels obtained 
with PAE-DMRIE at 100% were higher than those 
achieved with the optimal DMRIE/DOPE mixture (com- 
pare Fig. 4E, 0% DOPE with Fig. 45, 50% DOPE). 
The presentation of transfection data in the manner 
shown in Fig. 4 easily allows one to choose optimal 
transfection conditions for this particular B16FlO 
melanoma cell type. For example, using PAE-DMRIE, a 
near maximum transfection can be obtained by choosing 
the conditions in well E5 in Fig. 4A. Well E5, referring 
back to Fig. 3, contained 0.125 pg of DNA and 0.67 pg of 
PAE-DMRIE in the 100 ~1 transfection volume. The 
transfection conditions in well E5 might be preferred 
Cohlmn: 1 \ 2 
pg Cat. Lipid 10.7 j 5.34 
because the least amount of DNA and cationic lipid were 
used to give a near maximum reporter gene expression 
(shown as 10330 pg in well E5 in Fig. 4A). Similarly for 
DMRIE, one might choose well D6 in Fig. 4H where 
DMRIE was formulated with 50% DOPE and maximum 
transfection (7385 pg/well) was obtained using 0.25 pg 
of DNA and 0.33 pug of cationic lipid (about 0.66 pg of 
total lipid). 
To compare PAE-DMRIE and DMRIE more rigor- 
ously, nine additional sets of tumor and non-tumor produc- 
ing cells lines were transfected. The transfection data has 
been arranged in the same manner as with the B 16 
melanoma cells shown in Fig. 4, except that, in order to 
save space, the graphs have been miniaturized and the 
actual well-by-well pg values have been excluded. The 
data are shown in Fig. 5 for eight of the nine cell types 
comprising UM-449 (A), BHK (B), COS7 (C), 3T3 (D), 
C2C12 (E), Renca (F), HeLa (G), and CV- 1 (H) cells. As 
was the case for B 16 melanoma cells, PAE-DMRIE gener- 
ally transfected these tumoral and non-tumoral cell lines 
over a wider range of lipid and DNA concentrations and 
afforded as much or more total gene product than did 
DMRIE (in Fig. 5A-H compare the amount of solid and 
shaded areas in the left columns, #l-#5, with the right 
columns, #6-#IO). In all cases, PAE-DMRIE without 
co-lipid transfected cells much better than did DMRIE 
without co-lipid (in Fig. 5A-H, compare #5 and #lo, 0% 
DOPE bar values). 
The data in Fig. 5 also reveal that the range of DNA 
and cationic lipid concentrations that elicit the highest 
transfection (i.e., the black areas in each set of plates in 
Fig. 5) varies considerably between different cell types. 
For example, very low amounts of DNA and lipid are 
required to optimally transfect UM-449 cells (eg., Fig. 
5A- 1, well H-7 and Fig. 5A-6, well F-6) while rather high 
Row: (pM Cat. Lipid) 
A fig DNA: 2.000 
---Q@DNA): ___-___-___016_44)__-_ 
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H fig DNA: 0.016 
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Fig. 3. DNA/cationic lipid ratios used for in vitro transfection. An 8 X 8 titration matrix was set up in 96 well microplates by adding the indicated /~g 
(italics) and PM (italics in parenthesis) amounts of premixed RSVlacZ DNA/cationic lipid complexes to each well. The resulting mass ratios (bold) and 
micromolar concentrations (bold in parentheses) are indicated for each well in the matrix, DNA ‘molarity’ is based on M, of 330 per nucleotide monomer. 
These solutions in 100 ~1 were presented to cells in corresponding microplates for all the transfection assays used in this report. 
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Fig. 4. Comparison of transfection activity of PAE-DMRIE and DMRIE in murine Bl6FlO melanoma cells. The number of pg P-galactosidase produced 
per well are shown for each 8 X 8 transfection matrix. Each value is highlighted depending on whether that value fell in the upper (solid), middle (shaded) 
or bottom (open) one-third of the maximum pg value for that plate (for example, in A, maximum was I1 410 pg in well A-l). Shown are transfections 
using (A) /3AE-DMRIE alone; (B) 75% PAE-DMRIE plus 25 mol% DOPE; (C) 50% PAE-DMRIE plus 50% DOPE; (D) 25% PAE-DMRIE plus 75% 
DOPE; (F) DMRIE alone; (G) 75% DMRIE plus 25 mol% DOPE; (H) 50% DMRIE plus 50% DOPE; (I) 25% PAE-DMRIE plus 75% DOPE; The bar 
graphs show the sums of the pg values in the corresponding solid, shaded and open areas for PAE-DMRIE (E) and DMRIE (J). 
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Fig. 6. Comparison of total transfection activities of PAE-DMRIE and DMRIE and their optimal formulations with DOPE among different cell types. The 
sum of pg P-galactosidase values from each 8 X 8 matrix from Figs. 4 and 5 were determined and expressed as the percentage of the pg sum value for 
PAE-DMRIE alone (value shown in bold above each set of solid bars). Bars are shown for PAE-DMRIE alone (solid, = 100%); the optimal 
PAE-DMRIE-DOPE formulation (shaded); DMRIE alone (vertical hatching); and the optimal DMRIE-DOPE formulation (horizontal hatching). 
DNA and lipid amounts are required to maximally trans- 
feet 3T3 cells (Fig. 5E-1, well 5C and Fig. 5E-6, well C3). 
As was the case for B16 cells and the data in Fig. 4, the 
data shown in Fig. 5 can be used to choose DNA and 
cationic lipid levels and DNA/lipid ratios needed for 
maximal transfection of each of the eight cell types shown. 
For the best transfections, one would generally choose 
DNA and cationic lipid concentrations and ratios present 
in the solid wells in Fig. 5. 
The total amounts of reporter gene product from each 
cell line, expressed as the percentage of product from 
transfections with PAE-DMRIE alone as shown in Figs. 4 
and 5 were plotted together to allow direct comparison. 
The results are shown in Fig. 6. The various cell types 
exhibited a wide variation in the absolute amount of 
reporter gene expression as indicated by the pg/64 well 
total transfection value typed above each set of solid bars 
in Fig. 6. CT26 cells (the cells that expressed the least 
reporter gene product) exhibited a total transfection value 
of 4 ng/64 wells, while UM-449 melanoma cells (the cells 
that expressed the most gene product) exhibited a 141-fold 
higher transfection value of 664 ng/64 wells. The remain- 
ing cells showed transfection levels ranging between 4 and 
664 ng/64 wells. 
Despite this wide range of transfection efficiencies, 
PAE-DMRIE and DMRIE differed in four major ways 
from one another in their transfection efficiencies. First, 
/3AE-DMRIE without co-lipid transfected better than DM- 
RIE without co-lipid in 10 out of the 10 cell types exam- 
ined (Fig. 6, compare solid bars with vertically hatched 
bars). Second, @AE-DMRIE without co-lipid transfected 8 
out of 10 cell types as well or better than DMRIE opti- 
mally formulated with co-lipid (Fig. 6, compare solid bars 
with horizontally hatched bars). Third, /3AE-DMRIE with 
co-lipid transfected cells as well or better than DMRIE 
with co-lipid (Fig. 6 compare shaded bars with horizon- 
tally hatched bars). Fourth, DMRIE alone never trans- 
fected cells better than DMRIE optimally formulated with 
DOPE (Fig. 6, compare vertically hatched bars with hori- 
zontally hatched bars). Overall, then, PAE-DMRIE repre- 
sents a stand-alone cationic lipid molecule that can gener- 
ally elicit high transfection activity in the absence or 
presence of a co-lipid and over a wide range of cationic 
lipid and DNA concentrations. 
4. Discussion 
The synthesis of a novel cytofectin reagent, PAE- 
DMRIE, has been achieved. The structure and transfection 
Fig. 5. Comparison of transfection activity of PAE-DMRIE and DMRIE in selected tumoral and non tumoral cell lines. Eight sets of transfections were 
carried out in the same manner as that shown for B 16 cells in Fig. 4, except that the actual well-by-well pg values are not shown. Cells transfected include 
UM-449 (A), BHK (B), COS7 (Cl, 3T3 (D), C2C12 (E), R enca (F), HeLa (Cl and CV-1 (HI cells. Each well is highlighted depending on whether the pg 
P-galactosidase value from that well falls in the upper (solid), middle (shaded) or bottom (open) one-third of the maximum pg value for that plate. Shown 
at the bottom of each column of plates are bar graphs representing the sums of the corresponding solid, shaded and open pg/well values shown in the 
columns of data above each bar graph. 
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activity of DNA complexes with PAE-DMRIE has been 
compared with those with DMRIE, a cytofectin currently 
being used in human clinical trials [7,8,22]. The structural 
comparisons were done using Atomic Force Microscope. 
The AIM uses a sharp probe, mounted at the free end of a 
flexible cantilever, to scan and record the topography of a 
sample. The AFM has several features that are important 
for studying biological samples in that it: (i) produces 
images with a resolution equivalent to that of an electron 
microscope; (ii) yields topographic images directly; (iii) 
can operate in vacuum, air or aqueous buffers; (iv> follow 
dynamic molecular properties in real time; and (v> is easy 
to use for a wide range of biological samples [ 17,18,23]. 
Atomic force microscopy has not been used by past inves- 
tigators to visualize DNA/cationic lipid complexes. Here 
AFM was used to compare the structure of DNA/PAE- 
DMRIE and DNA/DMRIE-DOPE complexes. The 
DNA/PAE-DMRIE complexes appear consistently as 
compacted, irregularly shaped branches and rods, while 
DNA/DMRIE complexes could not be distinguished from 
images of free plasmid. The appearance of 
DNA/DMRIE-DOPE complexes by AIM was highly 
variable from one preparation to another, although a pre- 
dominant image was irregularly sized and shaped globules. 
Therefore, a single functional group change (OH of DM- 
RIE changed to NH, of PAE-DMRIE) resulted in a 
dramatic change in the ultrastructural appearance of 
DNA-liposome complexes, at least in those that bound to 
the mica surface during AFM processing. Further work 
will be needed to determine if the AFM images observed 
represent the majority of structures present in these 
DNA/cationic lipid complexes. 
We conclude that PAE-DMRIE is superior to DMRIE 
in mediating in vitro cellular transfection for the following 
reasons. PAE-DMRIE does not require the use of a neutral 
co-lipid in order to express high transfection activity, a 
feature that has the following advantages: (i) formulation 
with DNA is less complex, thereby decreasing work and 
expense; (ii) upon storage, unsaturated co-lipids can un- 
dergo hydrolytic and oxidative decomposition; (iii) co- 
lipids or their hydrolysis or oxidation products (such as 
lyso-phosphatidyl ethanolamine from DOPE) may have 
unwanted biological activities [24-271; and (iv> future 
studies designed to reveal DNA-lipid structure and eluci- 
date the cellular mechanism of transfection should be 
considerably simplified by the use of a single cationic lipid 
species. 
In addition to not requiring formulation with co-lipids, 
/?AE-DMRIE has other advantages. PAE-DMRIE has a 
broader range of DNA/cationic lipid ratios that elicit 
optimal transfection, thus allowing more flexibility in 
choosing the concentrations to present to cells. PAE- 
DMRIE appears to mediate the transfection of a wide 
range of tumoral and non-tumoral cell types. Also, solid 
PAE-DMRIE, unlike the individual solid components, 
DMRIE and DOPE, can be dissolved directly in aqueous 
media for immediate combination with DNA. And finally, 
the single compound, PAE-DMRIE, is simpler and less 
expensive to synthesize as the two separate compounds, 
DMRIE and DOPE. 
As shown above, a single change in the structural 
chemistry of DMRIE, e.g., the substitution of an amino 
group for an hydroxyl group, leads to dramatic increases in 
the ability of the cytofectin to deliver transcriptionally 
active DNA into cells. The two prerequisites for effective 
DNA delivery are that the positively charged cytofectin 
must interact with negatively charged DNA, and that the 
resulting DNA/cytofectin complex must interact with the 
negatively charged cellular plasmalemma. This raises a 
question concerning the identity of the critical structural 
features of cytofectins that enable them to deliver DNA 
into cells. Based on the pK, values of ethylenediamine 
[20], the amine group of PAE-DMRIE should confer 
additional positive charge to composite liposome structures 
compared to DMRIE. At the same time, the amine group 
in PAE-DMRIE should hydrogen bond at least as well as 
the hydroxyl of DMRIE. Thus, the additional cationic 
charge of PAE-DMRIE may enhance the ability of lipo- 
somes containing PAE-DMRIE to interact with DNA. If 
the PAE-DMRIE positive charge is maintained in excess 
over the negatively charged phosphates of DNA, the 
DNA/PAE-DMRIE liposomal complex should maintain a 
high electrostatic binding affinity to the negative cell 
surface. These properties may explain why PAE-DMRIE 
is able to deliver DNA to cells effectively over a greater 
range of concentrations than does DMRIE. Alternatively, 
PAE-DMRIE may be more effective than DMRIE for 
other, yet to be discovered reasons. 
PAE-DMRIE consistently transfects cells effectively in 
the absence of a co-lipid, while DMRIE and other cationic 
lipids examined to date, show significantly better transfec- 
tion activity when combined with neutral phospholipids 
([21]; unpublished observations). Previous reports [28-301 
have rationalized this need for co-lipids as the requirement 
for an easy transition between bilayer and hexagonal II 
phase states which the co-lipid is thought to confer to the 
liposome complex. The presence of a primary amine func- 
tion at the liposome surface has also been invoked as 
important in optimizing DMRIE activity, although this 
may not be generalizable since DOPC (which possesses a 
(CHJ3Nt in lieu of the NH: in DOPE) is an effective 
co-lipid for some cationic lipids [I I]. By analogy, PAE- 
DMRIE is an analog of DMRIE (in that NH, replaces 
OH), and an analog of DOPE (in that -N(CH,)l- replaces 
-o-PO,-0-X 
Thus, PAE-DMRIE may provide similar important 
coulombic, hydrophobic and hydrophilic properties to the 
macroscopic liposome as those provided by the combina- 
tion of DMRIE and DOPE. This would not, however, 
explain why /?AE-DMRIE actually elicits better transfec- 
tion than the optimal DMRIE-DOPE formulation. The 
complex relationship between lipid physico-chemistry and 
C.J. Wheeler et al. / Biochimica et Biophysics Acta 1280 (1996) l-l 1 11 
efficiency of cellilar transfection is unclear. Investigations 
are currently underway in this and other laboratories to 
shed more light on this important issue. 
The fact that a single substitution in the cytofectin 
skeleton can result in drastic changes in transfection prop- 
erties suggests that other modifications may also allow 
leaps in the improvement of gene delivery. This issue is 
currently being addressed by synthesizing and testing other 
analogues including the related propylene and butylene 
homologues of PAE-DMRIE. Structure-activity studies 
with such series of compounds may ultimately lead to the 
development of cytofectins with even more desirable prop- 
erties than PAE-DMRIE. 
Finally, the studies presented in this paper report only 
in vitro transfections. The mechanism of action and struc- 
tural properties of cytofectins that enable them to deliver 
DNA into cells in vivo is similarly not well understood. 
Thus, it is important to compare the transfection activity of 
DMRIE with that of PAE-DMRIE and other DMRIE 
analogues using in vivo transfection assays, and we are 
actively engaged in such pursuits. 
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